حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Q & M DENTAL GROUP (S) LIMITED
QC7Q & M Dental Group (Singapore) Limited, an investment holding company, provides private dental healthcare services in Singapore, Malaysia, China, and internationally. The company operates through Primary Healthcare, Dental Equipment and Supplies Distribution, and Medical Laboratory segments. It offers various aesthetic/cosmetic, CAD CAM digital, children, clear aligner, general, geriatric, and implant dentistry services; consultation, gum disease and surgery, intraoral 3D scanning, oral surgery, root canal treatment, scaling and polishing, teeth grinding and whitening, tooth-coloured filling, and wisdom tooth surgery services; and crowns and bridges, dental X-rays and AI scan, dentures, extractions, mouth and night guards, orthodontics, and sensitive teeth. The company also provides general health services, including adult and children consultation, chronic disease management, men's health, and skin care services; cervical PAP smear, family planning, general and pre-marital health screening, smoking cessation, and weight loss management services; and cervical cancer, chicken pox, childhood, hepatitis profiling, tetanus, typhoid, influenza, and travel advice and vaccinations. In addition, it offers pre-education/extracurricular activity certifications, and pre-employment checks; and ear syringing, draining of abscess, foreign materials and warts removal, suturing, and wound care and dressing services. Further, the company offers laboratory testing services, as well as sells Covid-19 test kits; and higher education programmes to dentists, as well as trades in dental surgery materials and equipment; and develops dental healthcare software and equipment. It operates dental and medical outlets, and a dental college. The company was founded in 1996 and is headquartered in Singapore. Q & M Dental Group (Singapore) Limited operates as a subsidiary of Quan Min Holdings Pte. Ltd. Address: No. 04-01 Logis Hub @ Clementi, Singapore, Singapore, 129809
Analytics
سعر الهدف في وول ستريت
0.48 SGDنسبة السعر إلى الأرباح
14.00العائد الربحي
3.32 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية QC7
تحليلات الأرباح QC7
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–نمو الأرباح على مدى 5 سنوات
36.00 %النمو المستمر
1 سنةمعدل الدفع 5 سنوات في المتوسط
115.00 %تاريخ الأرباح QC7
تقييم الأسهم QC7
المالية QC7
نتائج | 2019 | ديناميات |